Clinical Trials Directory

Trials / Unknown

UnknownNCT01448798

Athermal Nerve-sparing During Robotic-assisted Radical Prostatectomy Using a Hemostatic Matrix.

Prospective Randomized Investigation of Athermal Nerve-sparing During Robotic-assisted Laparoscopic Prostatectomy Using a Hemostatic Gelatin-thrombin Matrix

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Johann Wolfgang Goethe University Hospital · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the use of a hemostatic gelatine-thrombin matrix during athermal nerve-sparing prostate resection compared to conventional hemostasis using electrocautery in patients with localized prostate cancer and to investigate effects on postoperative erectile function and continence.

Conditions

Interventions

TypeNameDescription
PROCEDUREApplication of a hemostatic gelatin-thrombin matrixHemostatic gelatin-thrombin matrix is used for hemostasis during nerve-sparing dissection of the prostate.
PROCEDUREUse of mono- and bipolar electrocautery and surgical clipsMono- and bipolar electrocautery and surgical clips are used for hemostasis during nerve-sparing dissection of the prostate.

Timeline

Start date
2011-10-01
Primary completion
2013-01-01
Completion
2014-01-01
First posted
2011-10-07
Last updated
2011-10-07

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01448798. Inclusion in this directory is not an endorsement.

Athermal Nerve-sparing During Robotic-assisted Radical Prostatectomy Using a Hemostatic Matrix. (NCT01448798) · Clinical Trials Directory